Fang, XiaoChang
Shu, Lin
Chen, TianLiang
Zhao, XiaoLe
Yang, LiuCui
Dou, Tingting
Yang, Lijie
Li, Xuanfei
Feng, Maohui
Funding for this research was provided by:
The Clinical Medical Research Center of Peritoneal Cancer of Wuhan (2015060911020462, 2015060911020462, 2015060911020462, 2015060911020462, 2015060911020462, 2015060911020462, 2015060911020462, 2015060911020462, 2015060911020462)
The Clinical Research Projects of Wu JiePing Medical Foundation (320.6750.2023-11-9, 320.6750.2023-11-9, 320.6750.2023-11-9, 320.6750.2023-11-9, 320.6750.2023-11-9, 320.6750.2023-11-9, 320.6750.2023-11-9, 320.6750.2023-11-9)
Science and Technology Innovation Cultivation Fund of Zhong Nan Hospital of Wuhan University (CXPY2022055, CXPY2022055, CXPY2022055, CXPY2022055, CXPY2022055, CXPY2022055, CXPY2022055, CXPY2022055)
the Medical Science and Technology Innovation Platform Support Project of Zhong Nan Hospital of Wuhan University (PTXM2023004, PTXM2023004, PTXM2023004, PTXM2023004, PTXM2023004, PTXM2023004, PTXM2023004, PTXM2023004)
The National Natural Science Foundation of China (82070302, 82070302)
Article History
Received: 24 August 2023
Accepted: 15 November 2023
First Online: 10 January 2024
Declarations
:
: Ethics approval was granted by the Medical Ethics Committee of Zhongnan Hospital of Wuhan University (China) (No. 2015022, 2021054 and 2023005) and was conducted according to the Helsinki Declaration. Written informed consents were obtained from all patients. Animal experiments Approval was granted by Experimental Animal Welfare and Ethics, Zhongnan Hospital of Wuhan University (China) (No. ZN2023072).
: All authors give consent for publication of the manuscript in Molecular Cancer.
: The authors declare no competing interests.